Dersleri yüzünden oldukça stresli bir ruh haline sikiş hikayeleri bürünüp özel matematik dersinden önce rahatlayabilmek için amatör pornolar kendisini yatak odasına kapatan genç adam telefonundan porno resimleri açtığı porno filmini keyifle seyir ederek yatağını mobil porno okşar ruh dinlendirici olduğunu iddia ettikleri özel sex resim bir masaj salonunda çalışan genç masör hem sağlık hem de huzur sikiş için gelip masaj yaptıracak olan kadını gördüğünde porn nutku tutulur tüm gün boyu seksi lezbiyenleri sikiş dikizleyerek onları en savunmasız anlarında fotoğraflayan azılı erkek lavaboya geçerek fotoğraflara bakıp koca yarağını keyifle okşamaya başlar
Functional Proteomics For Biomarker And Drug Discovery | 17082
ISSN: 2155-952X

Journal of Biotechnology & Biomaterials
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 1770

Journal of Biotechnology & Biomaterials received 1770 citations as per Google Scholar report

Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • ResearchBible
  • China National Knowledge Infrastructure (CNKI)
  • Access to Global Online Research in Agriculture (AGORA)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Functional proteomics for biomarker and drug discovery

5th World Congress on Biotechnology

Manuel Fuentes

ScientificTracks Abstracts: J Biotechnol Biomater

DOI: 10.4172/2155-952X.S1.027

In post-genome era having sequence the human genome, one of the most important pursuits is to understand the function of gene-expressed proteins. The overwhelming size and complexity of human proteome requires very high-throughput techniques for rapid analysis. Despite significant advancements in molecular biology and genetic tools, this demand has not been satisfied and only a small fraction of the proteome has been understood at the biochemical level. Systems Biology and Proteomics strive to create detailed predictive models for molecular pathways based upon quantitative behavior of proteins. Understanding these dynamics networks provides clues into the consequence of aberrant interactions and why they lead to diseases such as cancer. Historically, methods capable of collecting quantitative data on biochemical interactions could only be used for one or a few proteins at the time. Protein microarrays allow hundreds to thousands of proteins to be analyzed simultaneously, providing an attractive option for high-throughput studies such as protein-protein interaction, differential protein profiles. Here, a novel approach based on combination of nanotechnology and proteomics tools for biomarker and drug discovery useful for earlier diagnosis and personalized medicine will be presented.
Manuel Fuentes graduated in Chemistry and Biochemistry from the University of Salamanca (Spain). After his Master?s in Biotechnology from University of Bielefeld (Germany), he joined at Biocatalysis Department at National Spanish Research Council (Madrid, Spain) for his PhD Thesis, entitled ?Design and development of conjugation and immobilization methods of biomolecules for diagnostic methods useful in Genomics and Proteomics?. Afterwards, he moved to Harvard Institute of Proteomics at Harvard Medical School (Boston, EE.UU.), during almost 6 years, when he was working on biomarker and drug discovery in tumor and autoimmune pathologies by using a combination of high-throughput label-free proteomics approaches. In 2009, he joined as a scientist at Cancer Research Center at University of Salamanca, where his research is focused on biomarker and drug discovery in hematological diseases, mainly for personalized medicine. He is co-author of 80 peer-reviewed papers (ISI web of Knowledge) in international journals, 9 licensed international patents, 10 book chapters, and more than 50 invited lectures in national and international meetings. In 2010, HUPO awarded him as ?HUPO Young Scientist? for his contributions in the field.